Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.90 |
---|---|
High | 1.90 |
Low | 1.90 |
Bid | 1.80 |
Offer | 1.88 |
Previous close | 2.02 |
Average volume | 411.00 |
---|---|
Shares outstanding | 52.48m |
Free float | 42.01m |
P/E (TTM) | -- |
Market cap | 94.46m EUR |
EPS (TTM) | -2.45 EUR |
Data delayed at least 15 minutes, as of Sep 20 2024 07:18 BST.
More ▼
Announcements
- Inventiva Reports Preliminary 2024 First-Half Financial Information¹
- Inventiva publie ses informations financières préliminaires du premier semestre 2024¹
- Inventiva obtient un nouveau brevet au Japon, élargissant la protection de la propriété intellectuelle de lanifibranor
- Inventiva secures a new patent in Japan, expanding the IP protection of its lead product candidate lanifibranor
- Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux
- Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
- Inventiva annonce l'émission de certificats de royalties pour un montant de 20,1 millions d'euros
- Inventiva announces a €20.1 million issuance of royalty certificates
- Inventiva provides an update on its NATiV3 clinical program evaluating lanifibranor in patients with MASH/NASH and its financial position
- Inventiva fait le point sur son programme clinique NATiV3 évaluant lanifibranor dans la MASH/NASH et sur sa situation financièr
More ▼